Shandong Realcan Pharmaceutical Co Ltd (002589) — Cash Flow-to-Debt Ratio
Shandong Realcan Pharmaceutical Co Ltd (002589) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥-15.60 Million could theoretically repay 0% of its total liabilities (CN¥9.87 Billion) in one year. See 002589 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Realcan Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2008–2024)
Historical debt coverage capacity for Shandong Realcan Pharmaceutical Co Ltd across 17 annual periods. Also explore 002589 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shandong Realcan Pharmaceutical Co Ltd (2008–2024)
Year-by-year debt coverage analysis for Shandong Realcan Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Shandong Realcan Pharmaceutical Co Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.02x | CN¥160.44 Million | CN¥10.32 Billion | ▲ +108.8% |
| 2023 | 0.01x | CN¥82.47 Million | CN¥11.07 Billion | ▼ -82.1% |
| 2022 | 0.04x | CN¥523.07 Million | CN¥12.58 Billion | ▲ +56.8% |
| 2021 | 0.03x | CN¥442.95 Million | CN¥16.70 Billion | ▲ +38.3% |
| 2020 | 0.02x | CN¥414.96 Million | CN¥21.65 Billion | ▼ -79.7% |
| 2019 | 0.09x | CN¥2.09 Billion | CN¥22.21 Billion | ▲ +1200.2% |
| 2018 | -0.01x | CN¥-201.66 Million | CN¥23.53 Billion | ▲ +93.9% |
| 2017 | -0.14x | CN¥-2.42 Billion | CN¥17.31 Billion | ▲ +35.1% |
| 2016 | -0.22x | CN¥-1.76 Billion | CN¥8.15 Billion | ▼ -152.5% |
| 2015 | -0.09x | CN¥-466.26 Million | CN¥5.46 Billion | ▼ -101.2% |
| 2014 | -0.04x | CN¥-163.62 Million | CN¥3.85 Billion | ▲ +56.6% |
| 2013 | -0.10x | CN¥-274.46 Million | CN¥2.80 Billion | ▼ -26.5% |
| 2012 | -0.08x | CN¥-170.52 Million | CN¥2.20 Billion | ▲ +77.2% |
| 2011 | -0.34x | CN¥-475.03 Million | CN¥1.40 Billion | ▼ -668.9% |
| 2010 | 0.06x | CN¥70.56 Million | CN¥1.18 Billion | ▼ -21.7% |
| 2009 | 0.08x | CN¥61.38 Million | CN¥805.78 Million | ▲ +192.2% |
| 2008 | -0.08x | CN¥-49.88 Million | CN¥603.64 Million | — |